150 related articles for article (PubMed ID: 14938938)
1. Tetraethyl pyrophosphate in the myasthenia gravis.
NOVOTA OJ
Mo Med; 1952 Feb; 49(2):133-4. PubMed ID: 14938938
[No Abstract] [Full Text] [Related]
2. Myasthenia gravis: report of a case with exophthalmos, without hyperthyroidism, relieved by neostigmine.
HATCH HA
N Engl J Med; 1952 May; 246(22):856-8. PubMed ID: 14929332
[No Abstract] [Full Text] [Related]
3. Observations of the effects of tetraethyl pyrophosphate in man, and on its use in the treatment of myasthenia gravis.
GROB D; HARVEY AM
Bull Johns Hopkins Hosp; 1949 Jun; 84(6):532-67. PubMed ID: 18151257
[No Abstract] [Full Text] [Related]
4. Studies in myasthenia gravis: present status of therapy with octamethyl pyrophosphoramide (OMPA).
OSSERMAN KE; KAPLAN LI
Ann Intern Med; 1954 Jul; 41(1):108-11. PubMed ID: 13171793
[No Abstract] [Full Text] [Related]
5. The conservative treatment of myasthenia gravis.
AIRD RB; CAMPBELL MB
Calif Med; 1950 Oct; 73(4):334-5. PubMed ID: 14772658
[TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis; the rationale of present day therapy.
PITTS CN; LEE EH
J Natl Med Assoc; 1952 Nov; 44(6):426-34. PubMed ID: 13000420
[No Abstract] [Full Text] [Related]
7. [Therapy of myasthenia gravis; clinical experiences with the treatment of myasthenia gravis pseudoparalytica with pyridostigmine].
SEIBERT P
Dtsch Med Wochenschr; 1953 May; 78(22):805-7. PubMed ID: 13067995
[No Abstract] [Full Text] [Related]
8. Kinetics and metabolism of intramuscular neostigmine in myasthenia gravis.
Somani SM; Chan K; Dehghan A; Calvey TN
Clin Pharmacol Ther; 1980 Jul; 28(1):64-8. PubMed ID: 7389256
[TBL] [Abstract][Full Text] [Related]
9. Report of a case of myasthenia gravis.
BRYAN FA
J Indiana State Med Assoc; 1956 Mar; 49(3):257-8. PubMed ID: 13306994
[No Abstract] [Full Text] [Related]
10. MYASTHENIA gravis.
Br Med J; 1956 Jun; 1(4978):1283-4. PubMed ID: 13316135
[No Abstract] [Full Text] [Related]
11. [Treatment of myasthenia gravis pseudoparalytica].
UNTERHARNSCHEIDT F
Nervenarzt; 1955 Jul; 26(7):275-9. PubMed ID: 13265940
[No Abstract] [Full Text] [Related]
12. Myasthenia gravis--the first 100 years in perspective.
Harvey AM
Trans Am Clin Climatol Assoc; 1971; 82():149-69. PubMed ID: 4934016
[No Abstract] [Full Text] [Related]
13. [A case of myasthenia gravis treated with hormones, clinical and experimental study].
HALVORSEN KA; MIHALIEVIC D
Dia Med; 1956 Aug; 28(60):1846-52. PubMed ID: 13375344
[No Abstract] [Full Text] [Related]
14. Myasthenia gravis; results of medical management.
FERGUSON FR; HUTCHINSON EC; LIVERSEDGE LA
Lancet; 1955 Sep; 269(6891):636-9. PubMed ID: 13252945
[No Abstract] [Full Text] [Related]
15. [Treatment of myasthenia gravis pseudoparalytica; clinical testing and therapy with BC substances (BC40, BC47, BC48 and BC 51)].
PATEISKY K
Wien Z Nervenheilkd Grenzgeb; 1959; 17():53-84. PubMed ID: 14430812
[No Abstract] [Full Text] [Related]
16. The relative merits of prostigmin and mestinon in the treatment of myasthenia gravis.
GUINENA YH; NABI SA; TAHER Y
J Egypt Med Assoc; 1956 Jun; 39(3):240-51. PubMed ID: 13367321
[No Abstract] [Full Text] [Related]
17. Octamethyl pyrophosphoramide in treatment of myasthenia gravis: further observations.
SCHULMAN S; RIDER JA; RICHTER RB
AMA Arch Neurol Psychiatry; 1953 May; 69(5):643-6. PubMed ID: 13039628
[No Abstract] [Full Text] [Related]
18. [Myasthenia gravis and enervation of the carotid sinus; presentation of two clinical cases with different number of years of evolution].
ROJAS CM
Vida Nueva; 1952 Jul; 70(1):29-33. PubMed ID: 13049744
[No Abstract] [Full Text] [Related]
19. Octamethyl pyrophosphoramide in the therapy of myasthenia gravis.
GREGORY L; FUTCH ED; STONE CT
Am J Med; 1952 Oct; 13(4):423-7. PubMed ID: 12985599
[No Abstract] [Full Text] [Related]
20. [Chemotherapy of myasthenia].
BAUER H; SCHMID O
Dtsch Z Nervenheilkd; 1953; 169(6):427-37. PubMed ID: 13083321
[No Abstract] [Full Text] [Related]
[Next] [New Search]